---
title: "Arcutis EVP, Chief Medical Officer Patrick Burnett disposes of USD 392,075.19 in common shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295860753.md"
description: "Arcutis Biotherapeutics EVP and Chief Medical Officer Patrick Burnett disposed of USD 392,075.19 worth of common shares on August 11-12. He exercised stock options to acquire 15,000 shares at $3.64 each, then sold the same number at weighted-average prices of $26.52 and $26.08. Following these transactions, his directly held common stock balance remained unchanged at 119,289 shares."
datetime: "2026-08-14T00:07:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295860753.md)
  - [en](https://longbridge.com/en/news/295860753.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295860753.md)
---

# Arcutis EVP, Chief Medical Officer Patrick Burnett disposes of USD 392,075.19 in common shares

-   Arcutis Biotherapeutics EVP, Chief Medical Officer Patrick Burnett exercised stock options on Aug. 11-12, acquiring 15,000 common shares at USD 3.64. \* Burnett sold 15,000 common shares on Aug. 11-12 at weighted-average prices of USD 26.52 and USD 26.08. \* Directly held common stock ended unchanged at 119,289 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-056898), on August 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ARQT.US](https://longbridge.com/en/quote/ARQT.US.md)

## Related News & Research

- [Arcutis Biotherapeutics director Howard G. Welgus sells 4,730 common shares for $123,835.71](https://longbridge.com/en/news/296400256.md)
- [Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Patrick Burnett Sells 955 Shares of Stock](https://longbridge.com/en/news/295047702.md)
- [Did Profitability, Higher 2026 Guidance, and New Commercial Leadership Just Recast Arcutis Biotherapeutics' (ARQT) Investment Narrative?](https://longbridge.com/en/news/295147038.md)
- [Corcept Chief Business Officer Gary Charles Robb sells 10,000 shares for $1.16 million](https://longbridge.com/en/news/296267228.md)
- [Agilysys Insiders Sold Shares Worth Over $1.6M](https://longbridge.com/en/news/296401909.md)